Clinical outcomes of septal myectomy in hypertrophic cardiomyopathy with refractory symptoms: A single institutional experience from India

被引:0
|
作者
Maramreddy, Revanth [1 ,4 ]
Bahl, Ajay [2 ]
Tingnam, Shyam Kumar Singh [3 ]
机构
[1] Kasturba Med Coll & Hosp, Dept Cardiothorac Surg, Manipal, India
[2] PGIMER, Dept Cardiol, Chandigarh, India
[3] PGIMER, Dept Cardiothorac Surg, Chandigarh, India
[4] 1001B, Udupi 576104, Karnataka, India
来源
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH | 2023年 / 24卷
关键词
Hypertrophic cardiomyopathy; Left ventricular outflow tract; Mitral regurgitation; Systolic anterior motion; MITRAL REGURGITATION; OBSTRUCTIVE CARDIOMYOPATHY; RELIEF;
D O I
10.1016/j.cegh.2023.101408
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Myectomy is the surgical procedure for the treatment of hypertrophic cardiomyopathy (HCM) with refractory symptoms There is limited data available regarding the role of myectomy in HCM among the Indian population. This study is intended to assess the outcomes of myectomy in HCM.Methods: Change in the gradient across the left ventricular outflow tract and severity of mitral regurgitation after myectomy were studied using echocardiography. Functional status, exercise tolerance, and cardiac rhythm of the patients were studied before and after myectomy.Results: The study consists of eleven patients with HCM. Four patients were in NYHA grade II, seven were in NYHA grade III before surgery. After surgery nine were in NYHA grade I and two were in NYHA grade II. Exercise tolerance of the study group was in the range of 1 min before surgery and it improved to 6.27 min after surgery. LVOT gradient before surgery was 108.81 and 112.45 mm of Hg on TTE and TEE respectively and it was 17.9 and 15.63 mm of Hg on TEE and TTE respectively after myectomy. On TTE eight patients had severe MR and three had moderate MR before surgery, while nine of them had severe MR and two had moderate MR on TEE. In the immediate post-operative period nine had mild MR, one had moderate MR, whereas the remaining one patient underwent MVR. TTE at six months revealed mild MR in seven, moderate MR in two patients and one had no MR.Conclusions: Surgical septal myectomy is an effective treatment modality for obstructive HCM.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Clinical long-term outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in infants
    Schleihauf, Julia
    Cleuziou, Julie
    von Ohain, Jelena Pabst
    Meierhofer, Christian
    Stern, Heiko
    Shehu, Nerejda
    Mkrtchyan, Naira
    Kaltenecker, Emanuel
    Kuehn, Andreas
    Nagdyman, Nicole
    Hager, Alfred
    Seidel, Heide
    Lange, Ruediger
    Ewert, Peter
    Wolf, Cordula M.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 53 (03) : 538 - 544
  • [22] A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China
    Wang, Shuiyun
    Luo, Mingyao
    Sun, Hongtao
    Song, Yunhu
    Yin, Chaohua
    Wang, Liqing
    Hui, Rutai
    Hu, Shengshou
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (03) : 534 - 540
  • [23] Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy
    Guo, Hong-Chang
    Li, Jin-Hua
    Jiang, Teng-Yong
    Ren, Chang-Wei
    Dai, Jiang
    Zhou, Yu-Jie
    Lai, Yong-Qiang
    CHINESE MEDICAL JOURNAL, 2018, 131 (05) : 527 - 531
  • [24] Experience, outcomes and impact of delayed indication for video-assisted wide septal myectomy in 69 consecutive patients with hypertrophic cardiomyopathy
    Heredia Cambra, Tomas
    Donate Bertolin, Lucia
    Bel Minguez, Ana M.
    Hernandez Acuna, Carlos E.
    Schuler, Mona
    Perez Guillen, Manuel
    Margarit Calabuig, Juan A.
    Montero Argudo, Jose A.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 44 (02) : E149 - E155
  • [25] Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998-2010])
    Panaich, Sidakpal S.
    Badheka, Apurva O.
    Chothani, Ankit
    Mehta, Kathan
    Patel, Nileshkumar J.
    Deshmukh, Abhishek
    Singh, Vikas
    Savani, Ghanshyambhai T.
    Arora, Shilpkumar
    Patel, Nilay
    Bhalara, Vipulkumar
    Grover, Peeyush
    Shah, Neeraj
    Elder, Mahir
    Mohamad, Tamam
    Kaki, Amir
    Kondur, Ashok
    Brown, Michael
    Grines, Cindy
    Schreiber, Theodore
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (09) : 1390 - 1395
  • [26] Trans-Catheter Septal Myectomy for Hypertrophic Cardiomyopathy: Results From an Innovative Design and Testing
    Park, Jiheum
    Geirsson, Arnar
    Bonde, Pramod
    CIRCULATION, 2018, 138
  • [27] Clinical Predictors for Repeat Alcohol Septal Ablation in Refractory Hypertrophic Obstructive Cardiomyopathy
    Kitamura, Mitsunobu
    Takayama, Morimasa
    Amano, Yasuo
    Shibuya, Junsuke
    Matsuda, Junya
    Yoshinaga, Aya
    Nakamura, Syunichi
    Asai, Kuniya
    Takano, Hitoshi
    Shimizu, Wataru
    CIRCULATION, 2014, 130
  • [28] Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy
    Guo Hong-Chang
    Li Jin-Hua
    Jiang Teng-Yong
    Ren Chang-Wei
    Dai Jiang
    Zhou Yu-Jie
    Lai Yong-Qiang
    中华医学杂志英文版, 2018, 131 (05) : 527 - 531
  • [29] Single Center Experience of Percutaneous Septal Ablation in Patients With Hypertrophic Cardiomyopathy With A Novel Agent: Polidocanol
    Ates, Ahmet Hakan
    Sener, Yusuf Ziya
    Sahiner, Mehmet Levent
    Kaya, Ergun Baris
    Aytemir, Kudret
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 190 : 1 - 7
  • [30] Sex-based outcomes of surgical myectomy for hypertrophic cardiomyopathy: An analysis from the National Readmission Database
    Osman, Mohammed
    Syed, Moinuddin
    Osman, Khansa
    Patel, Brijesh
    Kawsara, Akram
    Kheiri, Babikir
    Balla, Sudarshan
    Masri, Ahmad
    Wei, Lawrence
    Bianco, Christopher M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 166 (02) : 504 - +